Physician profile
Armaan Amin-Javaheri
NPI 1144922071
$1,473.71
in general payments reported to CMS, 2019-2025
9 companies · $997 in 2025
The $997 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $476 · 2025: $997.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,473.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $335.04 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Polynovo North America LLC | $284.06 | 2025 | Novosorb Btm |
| Solventum Corporation | $216.06 | 2025 | V.A.C.Ulta, Prevena, V.A.C. Veraflo Cleanse Choice |
| Integra Lifesciences Corporation | $167.62 | 2024 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Tela Bio, INC. | $165.91 | 2024 | Ovitex 2s |
| Abbvie INC. | $130.00 | 2025 | |
| Checkpoint Surgical, INC | $74.45 | 2025 | Checkpoint Stimulators |
| Medical Device Business Services, INC. | $68.00 | 2025 | Na |
| Stryker Corporation | $32.57 | 2025 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Armaan Amin-Javaheri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.